Trial Profile
A Phase Ib ,Single Center, Open-labeling, Multiple Oral Dose Study to Assess the Safety, Tolerability PK and Efficacy Profile for Advanced Solid Tumor Patients in China
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Sep 2023
Price :
$35
*
At a glance
- Drugs Icaritin (Primary)
- Indications Advanced breast cancer; Liver cancer; Solid tumours
- Focus Adverse reactions
- 17 Jul 2015 New trial record